Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-02-14
2006-02-14
Carr, Deborah D. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S886000, C514S825000, C514S944000, C514S962000, C554S115000, C554S121000, C554S224000
Reexamination Certificate
active
06998421
ABSTRACT:
The present invention comprises a group of related lipid molecules, and methods for their use, that maybe used to treat inflammation and certain inflammation related diseases. The group of related lipid molecules are capable of inhibiting certain enzyme systems including phospholipase A2, and cyclooxygenase-2. The group of related lipid molecules of the invention may be characterized by specific structural characteristics, or by specific biological activity, including inhibition of the previously listed enzymes.
REFERENCES:
patent: 5001234 (1991-03-01), Bundy et al.
patent: 5122536 (1992-06-01), Perricone
patent: 5318970 (1994-06-01), Suzuki et al.
patent: 5451686 (1995-09-01), Garst
patent: 5659049 (1997-08-01), Franson et al.
patent: 5905088 (1999-05-01), Diaz et al.
patent: 6060082 (2000-05-01), Chen et al.
patent: 6060085 (2000-05-01), Osborne
patent: 6143770 (2000-11-01), Lane et al.
patent: 19909552 (2000-07-01), None
Biozone Laboratories, Inc.
Carr Deborah D.
GSS Law Group
Smith Gregory Scott
LandOfFree
Compounds and methods for inhibition of phospholipase A 2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for inhibition of phospholipase A 2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for inhibition of phospholipase A 2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3709751